Unusual Headaches Revealing Neurolupus In Lome: Case Report And Review Of Literature

Authors

Keywords:

Togo, Headaches, Neurolupus, Systemic Lupus Erythematosus

Abstract

Systemic lupus erythematosus (SLE) is a chronic idiopathic autoimmune disease that affects various organs, including the central nervous system (CNS) and peripheral nervous system (PNS). Neurological and psychiatric manifestations of systemic lupus erythematosus or neurolupus (NPSLE) may present as a headache. We report a case of neurolupus characterized by diagnostic wandering. The patient, a 38-year-old woman, was admitted because of persistent headaches refractory to analgesics in the context of chronic headaches that had developed since adolescence diagnosed as migraine. Her personal medical history was marked by pyrosis, polyarthralgias, dermatosis. She was admitted to the hospital with right hemicorporeal paresthesias and worsening headaches, and the clinical examination found hyperreflexia, a malar rash, multiple hypochromic sequelae lesions of dermatosis in all 4 limbs. Brain MRI showed a non-systematised left parieto-occipital lesion on T1 isosignal, T2 and FLAIR hypersignal, not enhanced by gadolinium. The cerebrospinal fluid showed a relative hyperproteinorrhea, the presence of red blood cells (05/mm³), and leukocytes (46/mm³). Blood biology found an inflammatory syndrome with moderate anaemia, an accelerated sedimentation rate of 100 mm at the first hour, a C-Reactive Protein (CRP) at 22.8 g/l (normal less than 5 g/l), positive rheumatoid factors, positive antinuclear antibodies in the indirect immunofluorescence assay (on Hep 10-20 slides), at a titer of 1/320, negative deoxyribonucleic acid antibodies and positive anti-Smith antibodies. The diagnosis of SLE was confirmed based on the American College of Rheumatology (ACR) criteria with a score of 23. Excluding primary and secondary headaches, the patient's headaches satisfied the criteria for NPSLE. She was treated with corticosteroids and then methotrexate. After 3 months of treatment, a regression of headaches and cerebral signal abnormalities was noted.

References

Schwartz N, Stock AD, Putterman C. Neuropsychiatric Lupus: New Mechanistic Insights and Future Treatment Directions. Nat. Rev. Rheumatol. 2019; 15: 137-152.

Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2): 288-291

Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS. Epidemiology of systemic lupus erythematosus. Expert Review of Clinical Immunology 2017 : 13 (8) :799 814.

Patel V. The Challenge of Neuropsychiatric Systemic Lupus Erythematosus: From Symptoms to Therapeutic Strategies. Diagnostics 2024; 14, 1186.

Unterman A, Nolte JES, Boaz M et al. Neuropsychiatric Syndromes in Systemic Lupus Erythematosus: A Meta-Analysis. Seminars in Arthritis and Rheumatism 2011; 41 (1): 1-11.

Adelowo O, Oguntona A, Ojo O. Neuropsychiatric systemic lupus erythematosus among Nigerians. Afr. J. Med. Med. Sci. 2009; 38: 33-38.

Mapoure NY, Same BF, Balla Nde JJ et al. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: about 108 cases in Cameroon. Pan African Medical Journal 2022; 42(241).

Teclessou JN, Saka B, Akakpo SA. Connective tissue diseases in the hospital setting in Lomé: a retrospective study of 231cases. Pan Afr Med J 2018; 30: 176.

Liang MH, Corzillius M, Bae SC et al. The American College of Rheumatology Nomenclature and Case Definitions for Neuropsychiatric Lupus Syndromes. Arthritis Rheum. 1999; 42: 599-608.

González LA, Toloza SM, Alarcón GS. Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus. Rheum Dis Clin North Am. 2014; 40:433-54, VII-VIII.

Kivity S, Agmon-Levin N, Zandman-Goddard G et al. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med 2015; 13(1): 43.

Nived O, Sturfelt G, Liang MH et al. The ACR Nomenclature for CNS Lupus Revisited. Lupus 2003; 12: 872-876.

Elolemy G, Al Rashidi A, Youssry D et al. Headache in patients with systemic lupus erythematosus: characteristics, brain MRI patterns, and impact. Egypt Rheumatol Rehabil 2021; 48(1):31.

Savadogo M, Diallo I, Lompo L. Infectious encephalitis at Yalgado Ouédraogo University Hospital in Ouagadougou. Rev Mali Infect Microbiol 2024; 19 (1): 42-44.

Tattevin P, Revest M, Lavoue S. Aseptic meningitis and meningoencephalitis. Reanimation 2008; 17(7): 639-650.

Justiz-Vaillant AA, Gopaul D, Soodeen S et al. Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment. Molecules 2024; 29: 747.

Cotton F, Bouffard-Vercelli J, Hermier M. MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations. La revue de médecine interne 2004; 25: 8-15.

Bae C, Fraser P, Liang MH. The epidemiology of systemic lupus erythematosus in populations of African ancestry. Arthritis Rheum 1999 ; 41 (12): 2090–2099.

Fatoye F, Gebrye T, et Mbada C. Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis. Rheumatol. Int. 2022; 42: 2097–2107.

Nie Y, Sun B, He X et al. The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLE. Arthritis Res Ther 2023; 25 (1): 50.

Li X, Xiang X, Sun J, et al. Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study. Modern Rheumatology 2020; 30 (2): 321 326.

Downloads

Published

19-02-2025

How to Cite

1.
Ephoevi-ga AM, Belo M, Guinhouya KM, Agba L, Anayo KN, Talabewui A, et al. Unusual Headaches Revealing Neurolupus In Lome: Case Report And Review Of Literature. EAJNS [Internet]. 2025 Feb. 19 [cited 2025 Feb. 22];4(1):44-51. Available from: https://theeajns.org/index.php/eajns/article/view/255

Issue

Section

Case reports

Categories

Most read articles by the same author(s)